Model and Baseline OP | HR | (95% CI) | P Value |
14-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.31 | (.87–1.98) | .20 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.73 | (1.18–2.55) | <.01 |
14-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.34 | (.83–2.14) | .23 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.53 | (.98–2.38) | .06 |
30-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.48 | (1.05–2.10) | .03 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.55 | (1.10–2.19) | .01 |
30-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.50 | (1.01–2.23) | .04 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.44 | (.97–2.13) | .07 |
Model and Baseline OP | HR | (95% CI) | P Value |
14-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.31 | (.87–1.98) | .20 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.73 | (1.18–2.55) | <.01 |
14-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.34 | (.83–2.14) | .23 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.53 | (.98–2.38) | .06 |
30-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.48 | (1.05–2.10) | .03 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.55 | (1.10–2.19) | .01 |
30-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.50 | (1.01–2.23) | .04 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.44 | (.97–2.13) | .07 |
Abbreviations: CI, confidence interval; H2O, water; HR, hazard ratio; OP, opening pressure.
Model adjusted for baseline Glasgow Coma Scale (GCS) score, seizures, focal neurologic deficits, cerebrospinal fluid (CSF) white blood cell count <5 cells/mL, CSF quantitative culture (log10 CFU/mL), hemoglobin. GCS score, seizures, and focal neurologic deficits are likely all on the causal pathway of the effects of elevated intracranial pressure.
Model and Baseline OP | HR | (95% CI) | P Value |
14-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.31 | (.87–1.98) | .20 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.73 | (1.18–2.55) | <.01 |
14-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.34 | (.83–2.14) | .23 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.53 | (.98–2.38) | .06 |
30-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.48 | (1.05–2.10) | .03 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.55 | (1.10–2.19) | .01 |
30-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.50 | (1.01–2.23) | .04 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.44 | (.97–2.13) | .07 |
Model and Baseline OP | HR | (95% CI) | P Value |
14-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.31 | (.87–1.98) | .20 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.73 | (1.18–2.55) | <.01 |
14-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.34 | (.83–2.14) | .23 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.53 | (.98–2.38) | .06 |
30-day mortality (n = 533): unadjusted model | |||
Baseline OP | |||
<200 mm H2O | 1.48 | (1.05–2.10) | .03 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.55 | (1.10–2.19) | .01 |
30-day mortality (n = 470): adjusted modela | |||
Baseline OP | |||
<200 mm H2O | 1.50 | (1.01–2.23) | .04 |
200–350 mm H2O | REF | … | |
>350 mm H2O | 1.44 | (.97–2.13) | .07 |
Abbreviations: CI, confidence interval; H2O, water; HR, hazard ratio; OP, opening pressure.
Model adjusted for baseline Glasgow Coma Scale (GCS) score, seizures, focal neurologic deficits, cerebrospinal fluid (CSF) white blood cell count <5 cells/mL, CSF quantitative culture (log10 CFU/mL), hemoglobin. GCS score, seizures, and focal neurologic deficits are likely all on the causal pathway of the effects of elevated intracranial pressure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.